| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/14/2010 | CN101773479A Method for preparing shell-core double-layer microspheres |
| 07/14/2010 | CN101244272B Anti-solid tumors pharmaceutical combination containing topological enzyme inhibitor |
| 07/14/2010 | CN101172159B Acidic biological adhesion heat-variable gelling agent, its preparing method and uses |
| 07/13/2010 | US7756643 Method for determining the biological effect and/or activity of at least one drug, chemical substances and/or pharmaceutical composition based on their effect on the methylation status of DNA |
| 07/13/2010 | US7756559 Device for generating a detectable signal based upon antibody/antigen interaction |
| 07/13/2010 | US7754856 Human sodium-dependent bile acid transporter proteins |
| 07/13/2010 | US7754772 (2R)-2,3-bis(nitrooxy)propyl(2S)-2(6-methoxy(2-naphthyl)propanoate, used for treating inflammation, pain and fever; gastrointestinal disorders; wound healing agents; preventing gastrointestinal, renal and/or respiratory toxicities; side effect reduction |
| 07/13/2010 | US7754760 inducing endothelium-dependent vasodilation in a human or a veterinary animal by orally administering to the human or animal in need thereof a composition comprising an effective amount of epicatechin, and/or a pharmaceutically acceptable salt thereof, in combination with a food or beverage |
| 07/13/2010 | US7754753 Potentiating an NSAID and/or acetaminophen analgesic by administering concurrently a cyclooxygenase-2 inhibitor such as celecoxib, meloxicam, nimesulide and/or rofecoxib |
| 07/13/2010 | US7754748 Method for treating obesity |
| 07/13/2010 | US7754734 Administering one or more rapamycin derivatives (including rapamycin and 40-O-(2-hydroxy)ethyl-rapamycin); lymphocytic leukemia, lymphoma, Epstein-Barr virus, inhibiting graft rejection and metastasis; drug screening |
| 07/13/2010 | US7754716 vatalanib succinate (PTK787) and temozolomide; glioblastomas |
| 07/13/2010 | US7754678 fusion proteins; drug delivery |
| 07/13/2010 | US7754250 Drugs comprising plant extracts used for prevention amyloid formation, deposition or accumulation; amyloid fibrils, amylin fibrils, or islet amyloid fibrils or pre-deposited amyloid fibrils in type II diabetes; amyloid inhibitor |
| 07/13/2010 | US7754240 Solid at ambient temperature, softening point of </= 35 degrees C., when placed in continuous contact with skin it is softened to a consistency so substantial application of the unit dose is delivered in < 10 minutes |
| 07/13/2010 | US7754217 HMGB1 protein inhibitors and/or antagonists for the treatment of vascular diseases |
| 07/13/2010 | US7754200 Phosphate transport inhibitors |
| 07/13/2010 | US7754190 Neurophysiological information from quantitative electroencephalogram (QEEG) is used as the independent variable and medication response is analyzed as the dependent variable; observing the connection between neurophysiology and the clinical outcome of treatment; pharmakinetics |
| 07/13/2010 | CA2534006C Use of angiotensin ii receptor antagonists |
| 07/13/2010 | CA2449163C New use of 2-phenyl-substituted imidazotriazinones |
| 07/13/2010 | CA2446820C Novel pyrrole derivatives as pharmaceutical agents |
| 07/13/2010 | CA2444535C Formoterol/steroid bronchodilating compositions and methods of use thereof |
| 07/13/2010 | CA2440979C Spirolaximes for use in the treatment of pathologies that respond to ppar-.gamma. receptor activation |
| 07/13/2010 | CA2420350C Membrane penetrating peptides and uses thereof |
| 07/13/2010 | CA2372443C Local administration of anti-malarial agents for the treatment of inflammatory diseases |
| 07/13/2010 | CA2356533C Inhibitors of the bitter taste response |
| 07/13/2010 | CA2183564C Methods for altering fertility |
| 07/08/2010 | WO2010078449A2 Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
| 07/08/2010 | WO2010076851A1 Therapeutic/prophylactic agent for infections which relies on regulation of il-17a/il-17f |
| 07/08/2010 | WO2009049230A8 Microsphere-based materials with predefined 3d spatial and temporal control of biomaterials, porosity and/or bioactive signals |
| 07/08/2010 | WO2009024631A9 A combination of inhibitors of tgfbeta-1 and matrix metalloproteins for use in the treatment of bone metastases, bone resorption and hypercalcaemia |
| 07/08/2010 | US20100175141 Tunable genetic switch for regulating gene expression |
| 07/08/2010 | US20100173980 Antiviral oligonucleotides targeting rsv |
| 07/08/2010 | US20100173881 Compositions for the treatment of inflammatory disorders |
| 07/08/2010 | US20100173872 Method and Composition for Treating Alzheimer's Disease and Dementias of Vascular Origin |
| 07/08/2010 | US20100173327 Nonhuman model animal lacking the ability to control lymphocyte migration |
| 07/08/2010 | US20100173010 Polymetaphosphate based formulations for therapy of microcrystalline arthropathies |
| 07/08/2010 | US20100172973 Pharmaceutical Composition |
| 07/08/2010 | US20100172965 Antiviral oligonucleotides targeting viral families |
| 07/08/2010 | US20100172941 Adjuvant Compositions and Methods of Use |
| 07/08/2010 | US20100172905 Antagonists of hmg1 for treating inflammatory conditions |
| 07/08/2010 | US20100172903 Combination of an Anti-Ep-CAM Antibody with a Chemotherapeutic Agent |
| 07/08/2010 | US20100172896 Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases |
| 07/08/2010 | US20100172832 Diagnosis and treatment of malignant neoplasms |
| 07/08/2010 | US20100170849 Buffered compositions for dialysis |
| 07/08/2010 | DE102009005865A1 Dosiereinheit und Zusammensetzung zur Behandlung von entzündlichen Erkrankungen des Mund- und Rachenraums Dosing and composition for the treatment of inflammatory diseases of the mouth and throat |
| 07/08/2010 | CA2748607A1 Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
| 07/07/2010 | EP2204192A1 Prophylactic or therapeutic agent for inflammatory disease comprising thymidine phosphorylase inhibitor as active ingredient |
| 07/07/2010 | EP2203177A1 Methods and kits for the treatment of diverticular conditions |
| 07/07/2010 | EP2203168A2 Methods of treating a flaviviridae family viral infection and compositions for treating a flaviviridae family viral infection |
| 07/07/2010 | EP2203057A1 Method and compositions for treatment or prevention of inflammatory conditions |
| 07/07/2010 | EP1485099B1 Inhibitors of histone deacetylase |
| 07/07/2010 | EP1392301B1 Prevention of addiction in pain management with gamma vinyl gaba |
| 07/07/2010 | EP1383919B1 Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor |
| 07/07/2010 | EP1274834B1 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS |
| 07/07/2010 | EP0979284B2 Reagents for vaccination which generate a cd8 t cell immune response |
| 07/07/2010 | CN1859918B Use of hyaluronic acid for treating acute and overuse sprain and strain |
| 07/07/2010 | CN101772351A A novel bone mass increasing agent |
| 07/07/2010 | CN101766818A Polysaccharide gold-magnetic composite particle medicine carrier and preparation method thereof |
| 07/07/2010 | CN101766570A PH-sensitive precursor cation nanometer liposome of target tumour cell and preparation method thereof |
| 07/07/2010 | CN101766569A Long-acting antimicrobial medical oil emulsion and preparation method thereof |
| 07/07/2010 | CN101766549A Combination of monosaccharides and desquamating agents, and use thereof |
| 07/07/2010 | CN101766548A Combination of monosaccharides with solar filters and cosmetic use thereof |
| 07/07/2010 | CN101766547A Combination of monosaccharides with antioxidizing agents and cosmetic use thereof |
| 07/07/2010 | CN101229156B Medicine composition used for cardiovascular disorders |
| 07/06/2010 | US7750199 Kit systems for granulated decontamination formulations |
| 07/06/2010 | US7750164 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| 07/06/2010 | US7750050 Enhancing activity of an acid sphingomyelinase (ASM) protein with an analogue of ceramide, sphingomyelin or phosphonucleotide; gene therapy |
| 07/06/2010 | US7750041 Using antihyperplastic agent; diffusion through capillaries; imaging veins, arteries; side effect reduction; antitumor agents |
| 07/06/2010 | US7750030 Acute pharmacologic augmentation of psychotherapy with enhancers of learning or conditioning |
| 07/06/2010 | US7749987 treating with a mixture comprising nomegestrol acetate and estradiol valerate or estradiol; side effect reduction |
| 07/06/2010 | US7749981 Drug-eluting stents coated with non-nucleotide P2Y12 receptor antagonist compound |
| 07/06/2010 | US7749975 immunomers comprising at least two oligonucleotides linked at their 3' ends by internucleoside linkages, functionalized nucleobase or sugar to a non-nucleotidic linkers, used for treating cancer, autoimmune diseases, airway inflammation, inflammatory or skin disorders, allergy or asthma |
| 07/06/2010 | US7749970 Application of an azalide antibiotic such as azithromycin |
| 07/06/2010 | US7749962 administering to mammal with breast cancer as adjuvant therapy an agent effective in blocking interaction of integrin with extracellular matrix protein of bone marrow microenvironment or that downregulates expression of integrin; integrin is alpha 5 beta 1 and extracellular matrix protein is fibronectin |
| 07/06/2010 | US7749953 comprising regulating the expression or activity of cannabinoid receptors in bone cells |
| 07/06/2010 | US7749735 Interferon receptor variant for treatment and prevention of cell proliferative, autoimmune and viral diseases; prolonged activation of interferon beta |
| 07/06/2010 | US7749725 Monitoring sensitivity of humans to sodium; obtain fluid sample, measure concentration og angiotensin enzyme in sample, evaluate for sensitivity to sodium |
| 07/06/2010 | US7749718 Method for raising or isolating an antibody to DCRS5 |
| 07/06/2010 | US7749543 Methods useful in the treatment of bone resorption diseases |
| 07/06/2010 | US7749542 For preventing oral abuse of an oral opioid formulation; provides a negative, "aversive" experience when a large amount of the opioid, e.g., about 2-3 times the usually prescribed dose, is taken by or administered to a physically dependent subject |
| 07/06/2010 | US7749522 Organ arrest, protection and preservation |
| 07/06/2010 | US7749520 cationic liposomes containing alpha, alpha'-trehalose 6,6' dibehenate, ceramide and ganglioside, prepared from bromide salt of dimethyldioctadeceylammonium; drug delivery; immunology, vaccines |
| 07/06/2010 | US7749500 Antibodies to IL-17 polypeptides and therapeutic uses thereof |
| 07/06/2010 | US7749494 Use of hydrogenotrophic acetogenic strains for preventing or treating digestive disorders |
| 07/06/2010 | US7749490 Modified interleukin 10 polypeptide for use in treatment and prevention of neuropathic pain, neurological and inflammatory disorders |
| 07/06/2010 | US7749488 Topical drug delivery of an aerosol foam containing benzoyl peroxide, clindamycin or salt or ester, water, surfactant, buffer, xanthan gum, emollient and propellant; non-runny, easy to apply, and uses a low residue vehicle; quick-breaking foam |
| 07/06/2010 | US7748379 Methods and apparatus for relieving headaches, rhinitis and other common ailments |
| 07/06/2010 | CA2522761C Folic acid-containing pharmaceutical compositions, and related methods and delivery systems |
| 07/06/2010 | CA2460222C Eustachian tube stent |
| 07/06/2010 | CA2454863C Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 07/06/2010 | CA2415962C Valsartan salts |
| 07/06/2010 | CA2382129C Novel derivatives of flavones, xanthones and coumarins |
| 07/06/2010 | CA2365844C Texture masked particles containing an active ingredient |
| 07/06/2010 | CA2288059C Method of treating malignancies |
| 07/01/2010 | WO2010075545A1 Method for inducing a trif-bias |
| 07/01/2010 | WO2010075347A2 Methods of treating hypertension with at least one angiotensin ii receptor blocker and chlorthalidone |
| 07/01/2010 | WO2010075332A1 Small molecule ligands of the integrin rgd recognition site and methods of use |
| 07/01/2010 | WO2010074271A1 Therapeutic agent for diabetes |
| 07/01/2010 | WO2010074163A1 Complex and manufacturing method therefor |